Unity Biotechnology (UBX) Stock Pops on Positive Study Data
Source: Shutterstock Unity Biotechnology (NASDAQ:UBX) stock is gaining on Tuesday after the company released results from a Phase 2 clinical
Read moreSource: Shutterstock Unity Biotechnology (NASDAQ:UBX) stock is gaining on Tuesday after the company released results from a Phase 2 clinical
Read moreSource: Shutterstock Catalent (NYSE:CTLT) stock is falling hard on Tuesday as investors react to dismal results in its earnings report
Read moreSubscribe to our mailing list and get interesting stuff and updates to your email inbox.
Thank you for subscribing.
Something went wrong.